| Metric | სს ბიოფარმი | შპს ავალენზ |
|---|---|---|
| Growth | ||
| Revenue | ₾10.1m₾9.7m | ₾637k₾296k |
| Revenue growth | 4.8% | 114.8% |
| Profitability | ||
| EBITDA | -₾847k-₾427k | ₾44k-₾394k |
| EBITDA margin | -8.3%-4.4% | 6.9%-132.9% |
| Net profit | -₾1.3m-₾1.1m | -₾698k-₾793k |
| Net margin | -12.6%-11.5% | -109.7%-267.5% |
| Balance sheet | ||
| Total assets | ₾19.1m₾18.5m | ₾2.3m₾3.3m |
| Total equity | ₾18.2m₾17.1m | -₾4.1m-₾3.4m |
| ROE | -7.0%-6.5% | — |